Effects of vasoactive intestinal polypeptide (VIP), secretin and gastrin on insulin secretion in the mouse

@article{Ahrn2004EffectsOV,
  title={Effects of vasoactive intestinal polypeptide (VIP), secretin and gastrin on insulin secretion in the mouse},
  author={B. Ahr{\'e}n and I. Lundquist},
  journal={Diabetologia},
  year={2004},
  volume={20},
  pages={54-59}
}
SummaryThe in vivo effects of vasoactive intestinal polypeptide (VIP), secretin and two different molecular forms of gastrin, gastrin 17 and pentagastrin, on basal and stimulated insulin secretion have been investigated in the mouse. All these peptides induced a moderate dose-dependent increase in basal insulin secretion. The different polypeptides showed complex effects on insulin release stimulated by glucose, the cholinergic agonist carbachol or the β adrenergic agonist L… Expand
Role of VIP and PACAP in islet function
Vasoactive intestinal polypeptide increases whole pancreatic blood flow but does not affect islet blood flow in the rat
...
1
2
...

References

SHOWING 1-10 OF 41 REFERENCES
Stimulation of insulin and glucagon secretion by vasoactive intestinal peptide.
The augmentation effects of secretin on the insulin responses to known stimuli: specificity for glucose.
  • R. Lerner
  • Medicine
  • The Journal of clinical endocrinology and metabolism
  • 1977
The effect of gastrin on basal- and glucose-stimulated insulin secretion in man.
...
1
2
3
4
5
...